FDA Commissioner Says Addressing the Revolving Door Between the Agency & Big Pharma is a “Delicate Area“
“There are people who work within the FDA for a period of time. They have skills and knowledge about an area, and it’s an issue to say well they could never work in an industry where they might develop a cure for cancer or whatever the thing may be. So this is a delicate area…Yeah I mean there…It’s a complicated area…so I’m reluctant to just off the cuff, make a specific recommendation.”
Join
👉 @DrPaulMarik
https://cdn4.cdn-telegram.org/file/60be091f6b.mp4?token=Mbe2eNAjgAc1sdcCWVhzFeIJEAf2ihxJ7bbeGckjphnEXQfVXc3w0jkzgU8MhVI3_Y-1pWQLTWb-Ar9KDAU0uxWkcuAw2QwsW1iFQi5Wk1VDq3q6OVBOrg4on0w5FngxqsgID7YFZBaV6Mp3xhcl036V-Yhn2H7CHBpKr7e7idmBU0svYuERm0PRHiO1jCyFXMqiLMMettQQETodrCX4ZvVsWlXHKTx4SF_wEIzhol6KIBqUVDPrLTFXH6m3iGlTT6TNQPjeGMqehBVs5T3vTcY1UDuuuVXwv5h_IG8lJtrgUUwzWGEeShu86TjYVAn92zUheaiOSJX1CSRDTk71gA
Bei Telegram
